EU region sees increase in multinational trial initiation in Q1 2026
The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA) are seeing success in…
The European Commission (EC), the Heads of Medicines Agencies (HMA), and the European Medicines Agency (EMA) are seeing success in…
A new national framework designed to support the standardisation and expansion of advanced therapy clinical trials in the United Kingdom…
Today, 20 May, marks Clinical Trials Day. This year's theme, set by the Association of Clinical Research Professionals (ACRP), is "Research…
As we approach the end of H1, experts have shared their views on the main trends impacting clinical trials in…
China-based Vincentage Pharma is hot on Eli Lilly and Novo Nordisk’s heels after its oral glucagon-like peptide-1 receptor agonist (GLP-1RA)…
MSD’s TROP2-directed antibody-drug conjugate (ADC), sac-TMT, has shown benefit in both overall survival (OS) and progression-free survival (PFS) in a…
REGENXBIO is set to apply for US accelerated approval of its Duchenne muscular dystrophy (DMD) gene therapy after it showed…
Following news that started brewing last week, Dr Marty Makary has officially resigned from his post as commissioner of the…
It has been a turbulent few months for the US Food and Drug Administration (FDA), with redundancies, leadership changes and…
Fractyl Health’s trial to evaluate a glucagon-like peptide-1 (GLP-1) gene therapy has been approved by European authorities. The open-label, first-in-human,…